Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/305

Authors: Voss, KJ Welton, EJ Quinn, PK Frouin, R Miller, M Reynolds, RM
Citation: Kj. Voss et al., Aerosol optical depth measurements during the Aerosols99 experiment, J GEO RES-A, 106(D18), 2001, pp. 20811-20819

Authors: Miller, M
Citation: M. Miller, Barrett's esophagus: Major issues uncertain and unsolved, J NAT CANC, 93(9), 2001, pp. 674-675

Authors: Miller, M
Citation: M. Miller, Consensus on colorectal screening still difficult to achieve, J NAT CANC, 93(8), 2001, pp. 580-581

Authors: Miller, M Swan, J
Citation: M. Miller et J. Swan, SEER doubles coverage by adding registries for four states, J NAT CANC, 93(7), 2001, pp. 500-500

Authors: Miller, M
Citation: M. Miller, Are private dollars for research shifting diseases?, J NAT CANC, 93(4), 2001, pp. 264-265

Authors: Miller, M
Citation: M. Miller, Cancer incidence trends differ between Europe, United States, J NAT CANC, 93(19), 2001, pp. 1444-1445

Authors: Miller, M
Citation: M. Miller, Enrollment begins for largest-ever prostate cancer prevention trial, J NAT CANC, 93(15), 2001, pp. 1132-1132

Authors: Miller, M
Citation: M. Miller, Biomarkers, animal models key in progress of chemoprevention, J NAT CANC, 93(13), 2001, pp. 975-976

Authors: Miller, M
Citation: M. Miller, Overall cancer incidence, mortality rates continuing to fall, report shows, J NAT CANC, 93(11), 2001, pp. 809-809

Authors: Gisch, DJ Martinez, H Miller, M
Citation: Dj. Gisch et al., Methylene bridged resins yield enhanced osmotic stability in contacting with organic acid streams, J SEP SCI, 24(6), 2001, pp. 477-478

Authors: Deeks, SG Barditch-Crovo, P Collier, A Smith, A Miller, M McGowan, M Coakley, DF
Citation: Sg. Deeks et al., Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate, J ACQ IMM D, 28(4), 2001, pp. 336-339

Authors: Akporiaye, D Dahl, I Karlsson, A Plassen, M Wendelbo, R Bem, DS Broach, RW Lewis, GJ Miller, M Moscoso, J
Citation: D. Akporiaye et al., Combinatorial chemistry - The emperor's new clothes?, MICROP M M, 48(1-3), 2001, pp. 367-373

Authors: Rejeski, WJ Shelton, B Miller, M Dunn, AL King, AC Sallis, JF
Citation: Wj. Rejeski et al., Mediators of increased physical activity and change in subjective well-being: Results from the Activity Counseling Trial (ACT), J HEAL PSYC, 6(2), 2001, pp. 159-168

Authors: Kansal, S Miller, M
Citation: S. Kansal et M. Miller, Bilateral Duane syndrome with bilateral congenital glaucoma, J AAPOS, 5(5), 2001, pp. 325-326

Authors: Pollard, C Lewis, J Miller, M
Citation: C. Pollard et al., Start right-eat right award scheme: Implementing food and nutrition policyin child care centers, HEAL EDUC B, 28(3), 2001, pp. 320-330

Authors: De Cosa, B Moar, W Lee, SB Miller, M Daniell, H
Citation: B. De Cosa et al., Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formationof insecticidal crystals, NAT BIOTECH, 19(1), 2001, pp. 71-74

Authors: Miller, M Grabherr, M King, R Jager, R Michalzik, R Ebeling, KJ
Citation: M. Miller et al., Improved output performance of high-power VCSELs, IEEE S T QU, 7(2), 2001, pp. 210-216

Authors: Miller, M Grabherr, M Jager, R Ebeling, KJ
Citation: M. Miller et al., High-power VCSEL arrays for emission in the Watt regime at room temperature, IEEE PHOTON, 13(3), 2001, pp. 173-175

Authors: Neaigus, A Miller, M Friedman, SR Hagen, DL Sifaneck, SJ Ildefonso, G Des Jarlais, DC
Citation: A. Neaigus et al., Potential risk factors for the transition to injecting among non-injectingheroin users: a comparison of former injectors and never injectors, ADDICTION, 96(6), 2001, pp. 847-860

Authors: Miller, M Eskild, A Mella, I Moi, H Magnus, P
Citation: M. Miller et al., Gender differences in syringe exchange program use in Oslo, Norway, ADDICTION, 96(11), 2001, pp. 1639-1651

Authors: Kim, D Wang, LP Caldwell, CG Chen, P Finke, PE Oates, B MacCoss, M Mills, SG Malkowitz, L Gould, SL DeMartino, JA Springer, MS Hazuda, D Miller, M Kessler, J Danzeisen, R Carver, G Carella, A Holmes, K Lineberger, J Schleif, WA Emini, EA
Citation: D. Kim et al., Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection, BIOORG MED, 11(24), 2001, pp. 3099-3102

Authors: Kim, D Wang, LP Caldwell, CG Chen, P Finke, PE Oates, B MacCoss, M Mills, SG Malkowitz, L Gould, SL DeMartino, JA Springer, MS Hazuda, D Miller, M Kessler, J Danzeisen, R Carver, G Carella, A Holmes, K Lineberger, J Schleif, WA Emini, EA
Citation: D. Kim et al., Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection, BIOORG MED, 11(24), 2001, pp. 3103-3106

Authors: Willoughby, CA Berk, SC Rosauer, KG Degrado, S Chapman, KT Gould, SL Springer, MS Malkowitz, L Schleif, WA Hazuda, D Miller, M Kessler, J Danzeisen, R Holmes, K Lineberger, J Carella, A Carver, G Emini, EA
Citation: Ca. Willoughby et al., Combinatorial synthesis of CCR5 antagonists, BIOORG MED, 11(24), 2001, pp. 3137-3141

Authors: Hale, JJ Budhu, RJ Holson, EB Finke, PE Oates, B Mills, SG MacCoss, M Gould, SL DeMartino, JA Springer, MS Siciliano, S Malkowitz, L Schleif, WA Hazuda, D Miller, M Kessler, J Danzeisen, R Holmes, K Lineberger, J Carella, A Carver, G Emini, E
Citation: Jj. Hale et al., 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity, BIOORG MED, 11(20), 2001, pp. 2741-2745

Authors: Dorn, CP Finke, PE Oates, B Budhu, RJ Mills, SG MacCoss, M Malkowitz, L Springer, MS Daugherty, BL Gould, SL DeMartino, JA Siciliano, SJ Carella, A Carver, G Holmes, K Danzeisen, R Hazuda, D Kessler, J Lineberger, J Miller, M Schleif, WA Emini, EA
Citation: Cp. Dorn et al., Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes, BIOORG MED, 11(2), 2001, pp. 259-264
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>